Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Chang

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRIAndrea Pirzkall, Xiaojuan Li, Joonmi Oh, et al.
Journal of Neuro-Oncology|December 6, 2006
GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trialsSusan Chang, Michael Vogelbaum, Frederick F Lang, et al.
Neuro-Oncology Practice|August 9, 2020
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumorsJesus-Eduardo Rodriguez-Almaraz, Susan Chang, Jennifer Clarke, et al.
Neuro-Oncology|December 18, 2019
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effortAli S Haider, Martin van den Bent, Patrick Y Wen, et al.
Neuro-Oncology|August 2, 2005
High failure rate in spinal ependymomas with long-term follow-upDaniel R Gomez, Brian T Missett, William M Wara, et al.
Neuro-Oncology|September 1, 2016
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimenSarah J Nelson, Achuta K Kadambi, Ilwoo Park, et al.
AJNR. American Journal of Neuroradiology|February 15, 2005
Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imagingSoonmee Cha, Tarik Tihan, Forrest Crawford, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
Journal of Neuro-Oncology|February 22, 2012
The superiority of conservative resection and adjuvant radiation for craniopharyngiomasAdam Schoenfeld, Melike Pekmezci, Michael J Barnes, et al.
Neurosurgery|January 18, 2007
Genetic aberrations in gliomatosis cerebriMarcus L Ware, Yuichi Hirose, Bernd W Scheithauer, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRIAndrea Pirzkall, Xiaojuan Li, Joonmi Oh, et al.
Journal of Neuro-Oncology|December 6, 2006
GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trialsSusan Chang, Michael Vogelbaum, Frederick F Lang, et al.
Neuro-Oncology Practice|August 9, 2020
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumorsJesus-Eduardo Rodriguez-Almaraz, Susan Chang, Jennifer Clarke, et al.
Neuro-Oncology|December 18, 2019
Toward a standard pathological and molecular characterization of recurrent glioma in adults: a Response Assessment in Neuro-Oncology effortAli S Haider, Martin van den Bent, Patrick Y Wen, et al.
Neuro-Oncology|August 2, 2005
High failure rate in spinal ependymomas with long-term follow-upDaniel R Gomez, Brian T Missett, William M Wara, et al.
Neuro-Oncology|September 1, 2016
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimenSarah J Nelson, Achuta K Kadambi, Ilwoo Park, et al.
AJNR. American Journal of Neuroradiology|February 15, 2005
Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imagingSoonmee Cha, Tarik Tihan, Forrest Crawford, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
Journal of Neuro-Oncology|February 22, 2012
The superiority of conservative resection and adjuvant radiation for craniopharyngiomasAdam Schoenfeld, Melike Pekmezci, Michael J Barnes, et al.
Neurosurgery|January 18, 2007
Genetic aberrations in gliomatosis cerebriMarcus L Ware, Yuichi Hirose, Bernd W Scheithauer, et al.
Pageof 12